newsfilter
← Latest News
PR Newswire·

Citius Oncology Establishes International Access to LYMPHIR™ via Named Patient Programs in Southern Europe

Citius Oncology, Inc. ("Citius Oncology" or the "Company") (Nasdaq: CTOR), a specialty biopharmaceutical company focused on the development and...